Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to present at four investor conferences in April 2019.


Conference details:

William Blair 3rd Annual Late-Stage Therapeutics Conference
Date: Thursday, April 4, 2019
Location: New York, New York
 
Jefferies 6th Annual IO Cell Therapy Summit
Date: Friday, April 5, 2019
Presentation Time: 3:45 p.m. EDT     
Location: Boston, Massachusetts
 
HC Wainwright Global Life Sciences Conference
Date:Monday, April 8, 2019
Presentation Time: 10:10 a.m. CEST
Location:London, United Kingdom
Webcast: Celyad’s website, under Events & Webcasts section
 
Kempen Life Science Conference
Date:Tuesday, April 16, 2019
Presentation Time: 2.55 p.m. CEST
Location:Amsterdam, Netherlands

Download press release(s)

Press release

78.77 Ko

Communiqué de presse

88.94 Ko

Celyad to Present Update on allogeneic and autologous NKG2D-based CAR-T Candidates in Refr...

Next News

Celyad to Present Update on allogeneic and autologous NKG2D-based CAR-T Candidates in Refr...